Friday, July 10, 2026

pharma · Pain

Guangzhou General Hospital

Guangzhou General Hospital trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Intelligence · Clinical Trials

Guangzhou General Hospital clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Guangzhou General Hospital programs — each row shows trial ID, program name, phase, status, and indication.

Guangzhou General Hospital trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Guangzhou General Hospital.

  1. 0.33% ropivacaine 250ml — Approved

    Clinical update

Trial registry

1 studies